This content is PDF only. Please click on the PDF icon to access.
Thrombotic disease is one of the major health challenges today. Anticoagulants have had only limited success. Naturally occurring proteins such as streptokinase or urokinase, which activate plasmin and promote fibrinolysis, are expensive and require parenteral administration. Although of some therapeutic value, these agents are unsuitable for the prevention of clot formation. This book reviews and updates the search for synthetic, inexpensive oral agents that would activate the natural fibrinolytic system and might be of use in both the prevention and therapy of thromboembolic diseases.
The book is divided into 10 chapters representing the outlook, experimental data, and methodological approaches of
Learn more about subscription options.
Register Now for a free account.
Chemical Control of Fibrinolysis-Thrombolysis. Theory and Clinical Applications.. Ann Intern Med. 1971;74:152–153. doi: 10.7326/0003-4819-74-1-152_3
Download citation file:
Published: Ann Intern Med. 1971;74(1):152-153.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only